The Food and Drug Administration (FDA)
has published regulations to implement provisions of the Safe
Medical Devices Act (SMDA) of 1990 (Pub. L. 101-629) amending the
Food, Drug, and Cosmetic Act (the Act). Section 513 of the Act, as
amended by the SMDA on November 28, 1990, specifically section
513(i)(3), requires that a premarket notification filed under
section 510(k) shall include an adequate summary of any information
respecting safety and effectiveness (510(k) summary) or a statement
(510(k) statement) that such information will be made available
upon request by any person.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.